𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor

✍ Scribed by James R. Seibold; Anton H. M. Jageneau


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
787 KB
Volume
27
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Distribution of serotonin 5-HT2A recepto
✍ Michael Bubser; Jon R. Backstrom; Elaine Sanders-Bush; Bryan L. Roth; Ariel Y. D πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 366 KB πŸ‘ 3 views

Treatment with conventional antipsychotic drugs (APDs) is accompanied by extrapyramidal side effects (EPS), which are thought to be due to striatal dopamine D(2) receptor blockade. In contrast, treatment with atypical APDs is marked by a low incidence or absence of EPS. The reduced motor side effect

Rapid synthesis of [18F]SR46349B, a pote
✍ Pingzhong Tan; Joanna S. Fowler; Yu-Shin Ding; David J. Schlyer πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 483 KB

## Abstract F‐18 labeled SR46349B, a highly potent and selective 5‐HT~2~ receptor antagonist, was synthesized as a potential radioligand for PET studies of brain 5‐HT~2~ receptors. Nucleophilic aromatic substitution of __trans__‐1‐(2‐nitrophenyl)‐3‐(4‐methoxymethoxyphenyl)‐2‐propenone (10) with NCA